Analyst consensus rating
Insmed Analyst Rating: Strong Buy
INSM is rated Strong Buy by 22 analysts with a $200.18 target. As of 2026-08-27.
Direct answer
Insmed's consensus rating is Strong Buy.
22 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $200.18.
Forecast evidence checked August 27, 2026.
Get free Insmed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $124.39
- Average price target
- $200.18
- High price target
- $243.00
- Low price target
- $169.00
- Low target gap
- +35.9%
- Target upside
- +60.9%
- High target gap
- +95.4%
- Target range width
- 59.5%
- Consensus rating
- Strong Buy
- Analysts
- 22
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Insmed?
Insmed has a verified Strong Buy consensus. The same dataset has an average price target of $200.18.
How far are Insmed's low and high targets from the recorded price?
The low target implies +35.9%, while the high target implies +95.4%.
How many analysts are included in Insmed's consensus?
The verified consensus includes 22 analysts.
How is Insmed's target upside or downside calculated?
The average target of $200.18 is divided by the recorded price of $124.39, then one is subtracted to produce +60.9%. This does not guarantee a future return.
When was Insmed's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.